You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

failed bevacizumab

Showing 1 - 25 of 4,751
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer Trial (CA102N, TAS-102, Bevacizumab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • (no location specified)
Sep 8, 2023

Hepatocellular Carcinoma Trial in Vienna (FMT combined with Atezolizumab plus Bevacizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • FMT combined with Atezolizumab plus Bevacizumab
  • Vienna, Austria
    Medical University of Vienna
Feb 19, 2023

Metastatic Breast Cancer in the Liver Trial in Shanghai (Cryoablation Combined with Tirelizumab and Bevacizumab)

Recruiting
  • Metastatic Breast Cancer in the Liver
  • Cryoablation Combined with Tirelizumab and Bevacizumab
  • Shanghai, Shanghai, China
  • +1 more
Jun 6, 2022

Metastatic Liver Cancer Trial in Shanghai (HAIC?Bevacizumab?Camrelizumab)

Not yet recruiting
  • Metastatic Liver Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Dec 7, 2022

ALK Gene Mutation, Lung Adenocarcinoma, Immunotherapy Trial in Changsha (Pembrolizumab Combined With Bevacizumab and

Not yet recruiting
  • ALK Gene Mutation
  • +2 more
  • Pembrolizumab Combined With Bevacizumab and Chemotherapy
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Jul 14, 2022

Metastatic Microsatellite-stable Colorectal Cancer Trial in China (Experimental drug, Control Rx)

Recruiting
  • Metastatic Microsatellite-stable Colorectal Cancer
  • Experimental drug
  • Control Rx
  • Hefei, Anhui, China
  • +11 more
Mar 13, 2023

Glioma, Malignant Trial in Bangkok (ERC1671, GM-CSF, Cyclophosphamide)

Not yet recruiting
  • Glioma, Malignant
  • Bangkok, Vadhana, Thailand
    Bumrungrad International Hospital
May 9, 2022

Non Small Cell Lung Cancer Trial in Shanghai (Tislelizumab, Carboplatin, Pemetrexed)

Recruiting
  • Non Small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Nov 19, 2021

Patients With Advanced Refractory Solid Tumors

Not yet recruiting
  • Feasibility
  • +3 more
  • Targeted therapy
  • (no location specified)
Dec 14, 2021

Breast Cancer Trial in Zhengzhou (utidelone, Bevacizumab)

Recruiting
  • Breast Cancer
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Sep 15, 2022

Metastatic Cancer, Solid Tumor Trial in United States (bevacizumab, quality-of-life assessment)

Completed
Has Results
  • Metastatic Cancer
  • Unspecified Adult Solid Tumor, Protocol Specific
  • bevacizumab
  • quality-of-life assessment
  • Chicago, Illinois
  • +3 more
Sep 4, 2019

Breast Cancer Trial in Wuhan (Adebrelimab, dalpiciclib)

Recruiting
  • Breast Cancer
  • Wuhan, Hubei, China
    Tongji Hospital Affiliated of Tongji Medical College Huazhong Un
Nov 20, 2023

HER-2 Negative Breast Cancer Trial (Utidelone Combined with Bevacizumab)

Not yet recruiting
  • HER-2 Negative Breast Cancer
  • Utidelone Combined with Bevacizumab
  • (no location specified)
May 26, 2022

Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial (Atezolizumab Injection, Bevacizumab, Transarterial

Not yet recruiting
  • Hepatocellular Carcinoma
  • BCLC Stage B Hepatocellular Carcinoma
  • Atezolizumab Injection
  • +2 more
  • (no location specified)
Mar 16, 2023

Liver Metastasis Colon Cancer Trial in Guangzhou (TACE and HAIC Combined With Regorafenib)

Not yet recruiting
  • Liver Metastasis Colon Cancer
  • TACE and HAIC Combined With Regorafenib
  • Guangzhou, Guangdong, China
    the first affiliated hospital, Sun-Yat sen university
Oct 2, 2023

Non-Small-Cell Lung Cancer Stage IV Trial in Chongqing (Bevacizumab, Toripalimab, SBRT)

Recruiting
  • Non-Small-Cell Lung Cancer Stage IV
  • Chongqing, Chongqing, China
    Xinqiao Hospital of Chongqing
May 13, 2021

Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage IIA Lung Non-Small Cell Carcinoma AJCC v7, Stage IIB Lung Non-Small Cell

Active, not recruiting
Has Results
  • Stage IB Lung Non-Small Cell Carcinoma AJCC v7
  • +3 more
  • Bevacizumab
  • +7 more
  • Anniston, Alabama
  • +1174 more
Jan 28, 2023

Malignant Pleural Effusion Trial (bevacizumab and camrelizumab)

Not yet recruiting
  • Malignant Pleural Effusion
  • bevacizumab and camrelizumab
  • (no location specified)
Apr 8, 2022

Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Houston (VAL-083, Dianhydrogalactitol)

Active, not recruiting
  • Glioma
  • +4 more
  • VAL-083, Dianhydrogalactitol
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 23, 2022

Glioblastoma Multiforme, Glioblastoma, Glioma Trial in United States (VAL-083, Dianhydrogalactitol, Physician's Choice of

Terminated
  • Glioblastoma Multiforme
  • +4 more
  • VAL-083, Dianhydrogalactitol
  • +3 more
  • Los Angeles, California
  • +4 more
Nov 12, 2019

Advanced Pancreatic Carcinoma Trial in Shanghai (Fruquintinib)

Not yet recruiting
  • Advanced Pancreatic Carcinoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Feb 16, 2022

Hepatocellular Carcinoma Trial in Tianjin (HAIC, Adebrelimab, Bevacizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • HAIC
  • +2 more
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
Jul 27, 2023

Metastatic Colorectal Cancer Trial in ShangHai (Fruquintinib)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • ShangHai, Shanghai, China
    Fudan University Cancer Hospital
Jul 3, 2022

Advanced Colorectal Carcinoma Trial in Shanghai (Fruquintinib and raltitrexed, Fruquintinib)

Recruiting
  • Advanced Colorectal Carcinoma
  • Shanghai, Shanghai, China
    Fudan University Cancer Hospital
Oct 18, 2021

Metastatic Colorectal Cancer, KRAS Gene Mutation Trial in United States (Onvansertib, Bevacizumab, FOLFIRI)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • KRAS Gene Mutation
  • Phoenix, Arizona
  • +6 more
Nov 10, 2022